Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Hendriks

Showing results (21-30 of 344) with videos related to

Pageof 35
Sort By:
Lung Cancer (Amsterdam, Netherlands)|February 11, 2019
Is it time to incorporate surgery in the treatment of stage IV non-small cell lung cancer?Lizza E L Hendriks, Anne-Marie C Dingemans
Clinical Lung Cancer|July 19, 2021
Dorian Gray Syndrome of Upfront Immunotherapy in Patients With Non-Small-Cell Lung Cancer and High PD-L1 ExpressionLizza E L Hendriks, Jordi Remon, Benjamin Besse
The Veterinary Record|February 19, 1994
Screening for the illegal use of clostebol acetate in cattle by identification of its urinary metabolitesL Hendriks, B Gielen, L Leyssens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2022
The POSEIDON Trial: Will Secondary End Points Change Our Clinical Practice?Jordi Remon, Lizza E L Hendriks, Martin Reck
Expert Review of Anticancer Therapy|December 29, 2018
Prospects of targeted and immune therapies in SCLCLizza E L Hendriks, Jessica Menis, Martin Reck
The European Respiratory Journal|January 4, 2020
Current challenges in the management of nonsmall cell lung cancer brain metastasesLizza E L Hendriks, Jacques Cadranel, Thierry Berghmans
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 9, 2021
Malignant pleural mesothelioma: new guidelines make us stronger for defeating this diseaseJ Remon, L E L Hendriks, P Bironzo
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 21, 2022
Chemotherapy + PD-1/PD-L1 Blockade Should Not Be the Preferred Option in the Neoadjuvant Therapy of NSCLCLizza E L Hendriks, Jordi Remon, Martin Reck
European Journal of Cancer (Oxford, England : 1990)|March 21, 2022
Who benefits from consolidation durvalumab in stage III non-small cell lung cancer?Dirk De Ruysscher, Jordi Remon, Lizza E L Hendriks
The Lancet. Oncology|December 17, 2021
Postoperative radiotherapy in resected N2 non-small-cell lung cancer: Lung ARTLizza E L Hendriks, Dirk K M De Ruysscher
Pageof 35

Showing results (21-30 of 344) with videos related to

Sort By:
Pageof 35
Lung Cancer (Amsterdam, Netherlands)|February 11, 2019
Is it time to incorporate surgery in the treatment of stage IV non-small cell lung cancer?Lizza E L Hendriks, Anne-Marie C Dingemans
Clinical Lung Cancer|July 19, 2021
Dorian Gray Syndrome of Upfront Immunotherapy in Patients With Non-Small-Cell Lung Cancer and High PD-L1 ExpressionLizza E L Hendriks, Jordi Remon, Benjamin Besse
The Veterinary Record|February 19, 1994
Screening for the illegal use of clostebol acetate in cattle by identification of its urinary metabolitesL Hendriks, B Gielen, L Leyssens, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 4, 2022
The POSEIDON Trial: Will Secondary End Points Change Our Clinical Practice?Jordi Remon, Lizza E L Hendriks, Martin Reck
Expert Review of Anticancer Therapy|December 29, 2018
Prospects of targeted and immune therapies in SCLCLizza E L Hendriks, Jessica Menis, Martin Reck
The European Respiratory Journal|January 4, 2020
Current challenges in the management of nonsmall cell lung cancer brain metastasesLizza E L Hendriks, Jacques Cadranel, Thierry Berghmans
Annals of Oncology : Official Journal of the European Society for Medical Oncology|December 9, 2021
Malignant pleural mesothelioma: new guidelines make us stronger for defeating this diseaseJ Remon, L E L Hendriks, P Bironzo
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 21, 2022
Chemotherapy + PD-1/PD-L1 Blockade Should Not Be the Preferred Option in the Neoadjuvant Therapy of NSCLCLizza E L Hendriks, Jordi Remon, Martin Reck
European Journal of Cancer (Oxford, England : 1990)|March 21, 2022
Who benefits from consolidation durvalumab in stage III non-small cell lung cancer?Dirk De Ruysscher, Jordi Remon, Lizza E L Hendriks
The Lancet. Oncology|December 17, 2021
Postoperative radiotherapy in resected N2 non-small-cell lung cancer: Lung ARTLizza E L Hendriks, Dirk K M De Ruysscher
Pageof 35